| Aug 3 |
2 Unstoppable Dividend Stocks to Buy if There's a Stock Market Sell-Off
|
| Aug 2 |
DexCom, Abbott to benefit from the multi-billion-dollar OTC continuous glucose market
|
| Aug 2 |
Bio-Rad (BIO) Q2 Earnings Surpass Estimates, Guidance Lowered
|
| Aug 2 |
Abbott (ABT) Just Overtook the 200-Day Moving Average
|
| Aug 2 |
ResMed's (RMD) Q4 Earnings Surpass Estimates, Margins Expand
|
| Aug 2 |
As Diabetes Battle Heats Up, Spotlight Turns To Dexcom, Abbott
|
| Aug 2 |
Forget Johnson & Johnson: Another Healthcare Giant Is a Much Better Bet for Growth
|
| Aug 1 |
BD (BDX) Q3 Earnings Surpass Estimates, Margins Expand
|
| Aug 1 |
Avanos (AVNS) Q2 Earnings Top Estimates, Gross Margin Contracts
|
| Jul 31 |
7 Leading MedTech Stocks for Next-Gen Health Solutions
|
